[go: up one dir, main page]

FI972988L - Methods and pharmaceutical compositions using desmethylselegiline - Google Patents

Methods and pharmaceutical compositions using desmethylselegiline Download PDF

Info

Publication number
FI972988L
FI972988L FI972988A FI972988A FI972988L FI 972988 L FI972988 L FI 972988L FI 972988 A FI972988 A FI 972988A FI 972988 A FI972988 A FI 972988A FI 972988 L FI972988 L FI 972988L
Authority
FI
Finland
Prior art keywords
desmethylselegiline
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
FI972988A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972988A0 (en
FI972988A7 (en
Inventor
Cheryl D Blume
Anthony R Disanto
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of FI972988A0 publication Critical patent/FI972988A0/en
Publication of FI972988L publication Critical patent/FI972988L/en
Publication of FI972988A7 publication Critical patent/FI972988A7/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI972988A 1995-01-13 1996-01-11 Methods and pharmaceutical compositions using desmethyl selegiline FI972988A7 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37213995A 1995-01-13 1995-01-13
US1197995P 1995-07-31 1995-07-31
PCT/US1996/001561 WO1996022068A2 (en) 1995-01-13 1996-01-11 Methods and pharmaceutical compositions employing desmethylselegiline

Publications (3)

Publication Number Publication Date
FI972988A0 FI972988A0 (en) 1997-07-14
FI972988L true FI972988L (en) 1997-09-11
FI972988A7 FI972988A7 (en) 1997-09-11

Family

ID=23466867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972988A FI972988A7 (en) 1995-01-13 1996-01-11 Methods and pharmaceutical compositions using desmethyl selegiline

Country Status (4)

Country Link
JP (1) JP3036847B2 (en)
CN (1) CN100360123C (en)
FI (1) FI972988A7 (en)
WO (1) WO1996022068A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US6319954B1 (en) * 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
WO1996024346A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
DE19716905C1 (en) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Aqueous L-selegilin solution for treating Parkinson's disease
CA2322878C (en) 1998-03-16 2008-05-06 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
EP1117391A2 (en) * 1998-10-09 2001-07-25 L. Sai Latha Shankar Methods for treating multiple sclerosis
EP1621190A1 (en) * 1998-10-09 2006-02-01 L. Sai Latha Shankar Deprenyl compounds for treating Multiple Sclerosis
AU8679801A (en) * 2000-08-28 2002-03-22 Somerset Pharmaceuticals Inc Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
CA2474154A1 (en) * 2002-01-18 2003-07-24 Tatton Technologies, Llc. Methods for treating eye disorders
WO2003075906A1 (en) * 2002-03-04 2003-09-18 Somerset Pharmaceuticals, Inc. Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
CN116239476A (en) * 2022-11-28 2023-06-09 安徽贝克制药股份有限公司 A kind of preparation method of selegiline hydrochloride isomer
CN116077419B (en) * 2023-02-24 2023-10-27 丽珠集团新北江制药股份有限公司 Selaginella hydrochloride Ji Lantou skin absorbent for dogs and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
DK0690863T3 (en) 1993-04-06 2003-06-30 Abbott Lab Tetracyclic compounds as dopamine agonists
US5457121A (en) 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
US5616707A (en) 1995-01-06 1997-04-01 Crooks; Peter A. Compounds which are useful for prevention and treatment of central nervous system disorders

Also Published As

Publication number Publication date
CN1178462A (en) 1998-04-08
JPH10510542A (en) 1998-10-13
FI972988A0 (en) 1997-07-14
WO1996022068A3 (en) 1996-11-14
WO1996022068A2 (en) 1996-07-25
CN100360123C (en) 2008-01-09
JP3036847B2 (en) 2000-04-24
FI972988A7 (en) 1997-09-11

Similar Documents

Publication Publication Date Title
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
NO20004345D0 (en) Pharmaceutical composition
EE9900018A (en) Substituted pyridines, their use and pharmaceutical compositions
IS4706A (en) pharmaceutical compositions
FI964028L (en) New pharmaceutical formulation and method
FI973243A0 (en) New pharmaceutical combination
FI953898L (en) Glycinamide derivatives, methods for their preparation and pharmaceutical compositions containing them
FI951468A7 (en) Lipopeptide derivatives, method for their preparation and use
EE03825B1 (en) 2-Cyanoiminoimidazole derivatives, process for their preparation, use and pharmaceutical compositions
FI941836A7 (en) 3-Deoxyoligosaccharides, methods for their preparation and pharmaceutical compositions containing them
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
FI972988L (en) Methods and pharmaceutical compositions using desmethylselegiline
BR9509688A (en) Pharmaceutical composition and composition
BR9507768A (en) Pharmaceutical composition
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
BRPI9703099B8 (en) carbohydrate derivative, and pharmaceutical composition
FI973229L (en) New pharmaceutical composition
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
LV11727A (en) Pharmaceutical composition
FI953956A7 (en) 2,3-Ring-fused 1,4-dihydropyridines, methods for their preparation and their use as pharmaceuticals
ID18698A (en) PHARMACEUTICAL COMPOSITION
FI973280A7 (en) Pharmaceutical composition
BR9605777A (en) Pharmaceutical composition
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
BR9605131A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FD Application lapsed